Advancing Affordable Health Innovation for Africa

Improving Lives Through Research, Partnership and Patient Support

The Africa Patient Support Network (APSN) is a South African nonprofit organization dedicated to improving health outcomes across Sub-Saharan Africa through patient support, health education, ethical clinical research, and capacity strengthening.

Our mission is to help ensure that affordable, evidence-based health innovations reach the communities that need them most. We work with researchers, healthcare providers, universities, governments, and development partners to strengthen African-led research and improve access to quality healthcare.

Our Focus

  • Patient Support and Community Health

  • Health Education and Disease Awareness

  • Clinical Research and Innovation

  • Research Capacity Building

  • Ethics, Regulatory Science and Pharmacovigilance

  • Strategic Partnerships Across Africa

Our Vision

An Africa where every person has access to affordable, evidence-based healthcare and where African researchers lead innovations that improve public health.

Our Partners

Collaborating with top institutions across Africa and Europe to advance health research.

Our Strategic Research Partners

Connecting top institutions across Africa and Europe to advance health research together.

A diverse group of researchers collaborating around a table with laptops and documents, symbolizing international partnership.
A diverse group of researchers collaborating around a table with laptops and documents, symbolizing international partnership.

150+

15

Trusted Worldwide

50+

FAQs

What is APSN?

APSN connects research partners across Africa and Europe.

Who are your partners?

We collaborate with universities, hospitals, and research institutions.

Where are you located?

Our network spans multiple countries, including Uganda and several European nations.

How to join APSN?

Contact us via email to discuss partnership opportunities.

What projects do you run?

We focus on health research and clinical trials across regions.